PHARMOS, a.s. made a net profit of CZK 13.6 mil under revenues of CZK 10,628 mil in 2015, up 132% and -0.695%, respectively, when compared to the last year. This translates into a net margin of 0.128%.
Historically, the firm’s net profit reached an all time high of CZK 19.7 mil in 2006 and an all time low of CZK -27.0 mil in 2012. Since 2010, the firm's net profit has increased -5.65% or -1.16% a year on average.
On the operating level, EBITDA reached CZK 51.8 mil, up 14.5% when compared to the previous year. Over the last five years, company's EBITDA has grown -13.1% a year on average.
As far as PHARMOS, a.s.'s peers are concerned, Geco posted net and EBITDA margin of 1.23% and 1.67%, respectively in 2015.